Skip to content

Potassium acetate

BLOOD AND BLOOD FORMING ORGANS

Also known as: acetic acid, potassium salt

FDA approvedATC B05XA17

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Potassium acetate is a drug catalogued in DrugCentral. It was first approved by the FDA in 1971. Recorded indications include Hypokalemia and Hypokalemia Prevention.

  • Indications: Hypokalemia and Hypokalemia Prevention.
  • ATC code: B05XA17 (Electrolyte solutions).
  • Molecular formula: C2H3KO2; molecular weight 98.14 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Hypokalemia
  • Hypokalemia Prevention

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1971-09-24FDA—B BRAUN

ATC classification

ATC codeTherapeutic hierarchy
B05XA17BLOOD AND BLOOD FORMING ORGANS › BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS › I.V. SOLUTION ADDITIVES › Electrolyte solutions

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Gingival disorder35.6
Hypoaesthesia oral23.2
Restless legs syndrome21.6

Chemical structure

Molecular formulaC2H3KO2
Molecular weight98.14 g/mol
CAS number127-08-2
InChIKey—
PubChem CID517044

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Potassium acetate used for?

DrugCentral lists the following indications for Potassium acetate: Hypokalemia and Hypokalemia Prevention.

When was Potassium acetate first approved?

Potassium acetate was first approved by the FDA in 1971.

What is the chemical formula of Potassium acetate?

Potassium acetate has the molecular formula C2H3KO2 and a molecular weight of 98.14 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1971-09-24
AgencyFDA
Targets0
Indications2
FormulaC2H3KO2
DrugCentral ID4217
Interactive profile